Laughlin M - Search Results

1

Human immunodeficiency virus type 1 Tat activity in human neuronal cells: uptake and trans-activation.

Kolson DL, Collman R, Hrin R, Balliet JW, Laughlin M, McGann KA, Debouck C, Gonzalez-Scarano F. Kolson DL, et al. Among authors: laughlin m. J Gen Virol. 1994 Aug;75 ( Pt 8):1927-34. doi: 10.1099/0022-1317-75-8-1927. J Gen Virol. 1994. PMID: 8046394

2

CD4-independent infection of human neural cells by human immunodeficiency virus type 1.

Harouse JM, Kunsch C, Hartle HT, Laughlin MA, Hoxie JA, Wigdahl B, Gonzalez-Scarano F. Harouse JM, et al. Among authors: laughlin ma. J Virol. 1989 Jun;63(6):2527-33. doi: 10.1128/JVI.63.6.2527-2533.1989. J Virol. 1989. PMID: 2786088 Free PMC article.

3

Sodium butyrate treatment of cells latently infected with HIV-1 results in the expression of unspliced viral RNA.

Laughlin MA, Zeichner S, Kolson D, Alwine JC, Seshamma T, Pomerantz RJ, Gonzalez-Scarano F. Laughlin MA, et al. Virology. 1993 Oct;196(2):496-505. doi: 10.1006/viro.1993.1505. Virology. 1993. PMID: 8372431 Free article.

4

Entry of human immunodeficiency virus-1 into glial cells proceeds via an alternate, efficient pathway.

Harouse JM, Laughlin MA, Pletcher C, Friedman HM, Gonzalez-Scarano F. Harouse JM, et al. Among authors: laughlin ma. J Leukoc Biol. 1991 Jun;49(6):605-9. doi: 10.1002/jlb.49.6.605. J Leukoc Biol. 1991. PMID: 2026965

5

Human choroid plexus cells can be latently infected with human immunodeficiency virus.

Harouse JM, Wroblewska Z, Laughlin MA, Hickey WF, Schonwetter BS, Gonzalez-Scarano F. Harouse JM, et al. Among authors: laughlin ma. Ann Neurol. 1989 Apr;25(4):406-11. doi: 10.1002/ana.410250414. Ann Neurol. 1989. PMID: 2653176

6

Sodium butyrate stimulation of HIV-1 gene expression: a novel mechanism of induction independent of NF-kappa B.

Laughlin MA, Chang GY, Oakes JW, Gonzalez-Scarano F, Pomerantz RJ. Laughlin MA, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Aug 1;9(4):332-9. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7600100

7

Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide.

Harouse JM, Bhat S, Spitalnik SL, Laughlin M, Stefano K, Silberberg DH, Gonzalez-Scarano F. Harouse JM, et al. Among authors: laughlin m. Science. 1991 Jul 19;253(5017):320-3. doi: 10.1126/science.1857969. Science. 1991. PMID: 1857969

8

Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody.

Duan L, Bagasra O, Laughlin MA, Oakes JW, Pomerantz RJ. Duan L, et al. Among authors: laughlin ma. Proc Natl Acad Sci U S A. 1994 May 24;91(11):5075-9. doi: 10.1073/pnas.91.11.5075. Proc Natl Acad Sci U S A. 1994. Retraction in: Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10344. doi: 10.1073/pnas.95.17.10344-c PMID: 8197188 Free PMC article. Retracted.

9

Cellular latency in HIV-1 infection.

Laughlin MA, Pomerantz RJ. Laughlin MA, et al. Clin Lab Med. 1994 Jun;14(2):239-55. Clin Lab Med. 1994. PMID: 7924190 Review.

10

Amphipathic domains in the C terminus of the transmembrane protein (gp41) permeabilize HIV-1 virions: a molecular mechanism underlying natural endogenous reverse transcription.

Zhang H, Dornadula G, Alur P, Laughlin MA, Pomerantz RJ. Zhang H, et al. Among authors: laughlin ma. Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12519-24. doi: 10.1073/pnas.93.22.12519. Proc Natl Acad Sci U S A. 1996. PMID: 8901614 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

665 results

Search Page

Filters